https://imedic.health/en/health/news/ai-drug-discovery-heart-drug-failures-skepticism-clinical-trials iMedic en 2026-11-08 AI Drug Discovery Setbacks: What Heart Drug Failures Reveal About Hype and Biology https://imedic.health/en/health/news/gsk-moderna-patent-settlement-mrna-covid-rsv-vaccines-explained iMedic en 2026-11-08 GSK and Moderna Settle mRNA Patent Dispute: What It Means for COVID and RSV Vaccines https://imedic.health/en/health/news/lipoprotein-a-testing-who-should-be-checked-heart-risk iMedic en 2026-11-08 Lipoprotein(a) Testing: Who Should Be Checked for This Inherited Heart Risk Factor? https://imedic.health/en/health/news/surrogate-markers-cardiovascular-drug-trials-biomarker-outcomes iMedic en 2026-11-08 When a Drug Fixes the Biomarker but Not the Outcome: Lessons From Cardiovascular Trials https://imedic.health/en/health/news/osteoporosis-drugs-lower-dementia-risk-large-study iMedic en 2026-11-09 Osteoporosis Medications and Dementia Risk: What a Large Study of Older Adults Found https://imedic.health/en/health/news/engineered-immune-cells-glioblastoma-mice-ucsf-brain-activated-therapy iMedic en 2026-11-09 Brain-Activated CAR T Cells: How a New Immunotherapy Cleared Deadly Brain Tumors in Mice https://imedic.health/en/health/news/doxycycline-early-pregnancy-loss-risk-cohort-study iMedic en 2026-11-10 Doxycycline in Early Pregnancy: What a Cohort Study Says About Pregnancy Loss Risk https://imedic.health/en/health/news/fexofenadine-pseudoephedrine-allergy-congestion-fda-approval-what-to-know iMedic en 2026-11-10 Fexofenadine and Pseudoephedrine for Allergy Congestion: What an FDA Approval Means for Patients